Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Kathleen I. Pritchard
Based on 110 articles published since 2008
||||
Expertise Level
The expertise of Kathleen I. Pritchard ranks in the
  • Top 0.0043%
  • ... of 257,180 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 110 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Pritchard, Kathleen I   ·   Pritchard, Kathleen
Work Locations
Details
Most likely:    University of Toronto   Contact    
2018
  • Institute of Health Policy, Management and Evaluation, University of Toronto, Canada; Department of Oncology, Western University, London Regional Cancer Program, London, ON, Canada. Electronic address: · Institute of Health Policy, Management and Evaluation, University of Toronto, Canada; Department of Medical Oncology and Haematology, University of Manitoba and CancerCare Manitoba, MB, Canada. · Institute of Health Policy, Management and Evaluation, University of Toronto, Canada; Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, ON, Canada. · Department of Medicine, Sunnybrook Health Sciences Centre, ON, Canada. · Institute of Health Policy, Management and Evaluation, University of Toronto, Canada; Department of Pediatrics, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. · Pubmed 29331750
2017
  • Penn State Hershey Cancer Institute, Penn State Hershey Medical Center, Hershey, Pennsylvania. · Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. · Sunnybrook Odette Cancer Centre, Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada. · Oncology, Mayo Clinic, Rochester, Minnesota. · Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. · Stanford University Medical Center, Stanford, California. · International Breast Cancer Study Group Coordinating Center and Inselspital, Bern, Switzerland. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Lebanon VA Medical Center, Lebanon, Pennsylvania. · Pubmed 28464211
  • Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Children's Hospital of Eastern Ontario, Ottawa, ON, Canada. · University Health Network, University of Toronto, Toronto, ON, Canada. · Canadian Cancer Trials Group (CCTG), Cancer Research Institute, Queen's University, Kingston, ON, Canada. · British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada. · Dana-Farber Cancer Institute, Boston, MA, USA. · Columbia University Medical Center, New York, NY, USA. · National Surgical Adjuvant Breast and Bowel Project and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Mayo Clinic College of Medicine, Rochester, MN, USA. · Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, ON, Canada. · Juravinski Cancer Centre, Hamilton, ON, Canada. · Allan Blair Cancer Center, Regina, SK, Canada. · British Columbia Cancer Agency, Vancouver Island Center, University of British Columbia, Vancouver, BC, Canada. · Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Pubmed 28447237
  • Ian Smith and Mitch Dowsett, Royal Marsden Hospital · Institute of Cancer Research, London, United Kingdom · Denise Yardley and Howard Burris, Sarah Cannon Research Institute · Tennessee Oncology, Nashville, TN · Richard De Boer, Royal Melbourne and Western Hospitals, Melbourne, Australia · Dino Amadori, Istituto Scientifico Romagnolo per lo Studio e la Cura del Tumori Istituto di Ricovero eCura a Carattere Scientifico, Meldola · Lisa Comarella, CROS NT, Verona, Italy · Kristi McIntyre and Joyce O'Shaughnessy, Texas Oncology, US Oncology · Joyce O'Shaughnessy, Baylor University Medical Center · Baylor Charles A. Sammons Cancer Center · The US Oncology Network, Dallas, TX · Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark · Michael Gnant, Medical University of Vienna, Vienna, Austria · Walter Jonat, Universitätsklinikum Schleswig-Holstein, Kiel, Germany · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada · Lowell Hart, Florida Cancer Specialists, Fort Myers, FL · Susan Poggio and Barbara Wamil, Novartis Pharmaceuticals Corporation, East Hanover, NJ · and Herve Salomon, Novartis Pharma, Rueil-Malmaison, France. · Pubmed 28113032
  • From the Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford (H.P., R.G., J. Braybrooke, C.D., C.T., P.M., R.P.), and Royal Marsden Hospital and Institute of Cancer Research, London (M.D.) - both in the United Kingdom · Sunnybrook Health Sciences Centre and the University of Toronto, Toronto (K.I.P.) · Karolinska Institutet and Karolinska University Hospital, Stockholm (J. Bergh) · and the University of Michigan Comprehensive Cancer Center, Ann Arbor (D.F.H.). · Pubmed 29117498
  • Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 29031779
  • Physical Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Radiation Oncology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 28401902
  • Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada · British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Kaleidoscope Strategic, Inc., Toronto, Ontario, Canada. · Tom Baker Cancer Centre and University of Calgary, Alberta, Canada. · Deschênes-Fabia Center for Breast Disease, Quebec, Canada. · Division of Medical Oncology, Dalhousie University, and Atlantic Clinical Cancer Research Unit, Halifax, Nova Scotia, Canada. · Pubmed 27864574
2016
  • Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology, University of Western Ontario, London, Ontario, Canada. · Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 27776294
  • Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 27768924
  • Karolinska Institutet and University Hospital, Stockholm, Sweden · Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom. · Pubmed 26786914
  • a Department of Medicine , University of Toronto , Toronto , Canada. · Pubmed 27539883
  • Division of Geriatric Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. · AD Clinic, Centre for Brain Health, 2nd Floor 2215, Wesbrook Mall, Vancouver, V6T 1Z3, BC, Canada. · Department of Family & Community Medicine Faculty of Medicine, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Canada. · Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada. · Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Institute for Clinical Evaluative Sciences, Toronto, ON, Canada. · Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada. · Pubmed 27432418
  • Canadian Cancer Trials Group (Formerly, NCIC Clinical Trials Group), Queen's University, 10 Stuart St, Kingston, ON, Canada. · Massachusetts General Hospital, Harvard University, Boston, MA, USA. · bioTheranostics Inc, San Diego, CA, USA. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. · Canadian Cancer Trials Group (Formerly, NCIC Clinical Trials Group), Queen's University, 10 Stuart St, Kingston, ON, Canada. · McGill University, Montreal, QC, Canada. · Pubmed 27116182
  • Canadian Cancer Trials Group (formerly, NCIC Clinical Trials Group), Queen's University, Kingston, ON, Canada. · Canadian Cancer Trials Group (formerly, NCIC Clinical Trials Group), Queen's University, Kingston, ON, Canada. · Mayo Clinic, Rochester, MN, USA. · University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. · British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC, Canada. · Juravinski Cancer Centre at Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Pubmed 27006189
  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota. · Baylor Breast Center, Houston, Texas. · Massachusetts General Hospital Cancer Center, Harvard University, Boston, Massachusetts. · Canadian Cancer Trials Group, Kingston, Ontario, Canada. · RIKEN Center for Integrative Medical Science, Yokohama, Japan. · University of Tokyo, Tokyo, Japan. · Johns Hopkins School of Medicine, Baltimore, Maryland. · Sunnybrook Odette Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Pubmed 27758888
  • Physical Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. · Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Radiation Oncology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 27105515
  • Center for Oncology and Hematology, Wilhelminen Hospital, Vienna, Austria. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Royal Marsden Hospital, London, UK. Electronic address: · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. Electronic address: · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. Electronic address: · Mater Hospital, North Sydney, NSW, Australia. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Centre GF Leclerc, Dijon, France. Electronic address: · Northwestern University, Chicago, IL, USA. Electronic address: · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: · Arizona Oncology, US Oncology, Sedona, AZ, USA. Electronic address: · GlaxoSmithKline, Collegeville, PA, USA. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Pubmed 26829011
  • Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · bioTheranostics, Inc., San Diego, CA, USA. · bioTheranostics, Inc., San Diego, CA, USA. · Trovagene Inc., San Diego, CA, USA. · Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada. · Pubmed 26728744
  • Mark N. Levine, Jim A. Julian, and Louise Bordeleau, McMaster University, Hamilton · Mark N. Levine and Louise Bordeleau, Hamilton Health Sciences Juravinski Cancer Centre, Hamilton · Mark N. Levine and Jim A. Julian, Ontario Clinical Oncology Group and Escarpment Cancer Research Institute, Hamilton · Philippe L. Bedard, Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, University of Toronto, Toronto · Phillipe L. Bedard, Princess Margaret Hospital, Toronto · Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, Odette Sunnybrook Regional Cancer Centre · Toronto · and Brian Higgins, Peel Regional Cancer Centre, Mississauga, Ontario, Canada. · Pubmed 26598746
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX · David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ · Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels · Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium · Hope S. Rugo, University of California, San Francisco · Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA · Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada · Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain · Thomas Bachelot, Centre Léon Bérard, Lyon, France · Shinzaburo Noguchi, Osaka University Medical School · Norikazu Masuda, Osaka National Hospital, Osaka, Japan · Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL · Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ · Shaker Dakhil, Cancer Center of Kansas, Wichita, KS · Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA · and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2015
  • Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver · Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia · Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec · Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston · Susan Dent, Ottawa Health Research Institute, Ottawa · Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto · Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario · Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada · Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia · Bella Kaufman, Sheba Medical Centre, Tel Hashomer · Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel · Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg · Sergei Tjulandin, Russian Cancer Research Center, Moscow · Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia · Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy · Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain · Lee S. Schwartzberg, West Clinic, Memphis, TN · Arnd Nusch, Praxis, Velbert, Germany · Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom · Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan · Anne P. Connor, GlaxoSmithKline, Collegeville, PA · and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil. · Pubmed 25779558
  • Mater Hospital, Sydney, Australia. Electronic address: · Royal Marsden Hospital, London, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, United States. · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. · UT MD Anderson Cancer Center, Houston, TX, United States. · Centre GF Leclerc, Dijon, France. · Northwestern University, Chicago, IL, United States. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Massachusetts General Hospital, Boston, MA, United States. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. · Arizona Oncology, US Oncology, Sedona, AZ, United States. · GlaxoSmithKline, Collegeville, PA, United States; GlaxoSmithKline, Uxbridge, UK. · Pubmed 25752740
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (PJG) · NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (WRP, LES, BEC) · NCIC Clinical Trials Group, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada (KAG) · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (JAL) · Columbia University Medical Center, New York, NY (DLH) · National Surgical Adjuvant Breast and Bowel Project, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA (PR) · Vanderbilt-Ingram Medical Center, Vanderbilt University Medical Center, Nashville, TN (IAM) · Mayo Clinic College of Medicine, Rochester, MN (TJH) · Centre de recherche du CHU de Québec, Unité de recherche en santé des populations Hôpital du Saint-Sacrement, Quebec, Quebec, Canada (JL) · National Cancer Research Institute Breast Clinical Studies Group, London, UK (AMT) · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada (KIP) · Juravinski Cancer Center at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (TJW, SDM) · Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (HIC) · British Columbia Cancer Agency, Fraser Valley Center, Surrey, British Columbia, Canada (CDO) · University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada (KST) · British Columbia Cancer Agency - Vancouver Island Center, University of British Columbia, British Columbia, Canada (VB) · Ontario Cancer Institute, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada (VS). · Pubmed 25740979
  • Transformative Pathology, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Informatics and Bio-Computing, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. · Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Leeds Institute of Cancer and Pathology and Cancer Research UK Centre, St James' University Hospital, Leeds, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of Toronto, Toronto, ON, Canada. · McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. · NCIC Clinical Trials Group (NCIC CTG] and Queen's University, Kingston, ON, Canada. · Pubmed 26372731
  • Center for Oncology and Hematology, Wilhelminen Hospital, Montleartstrasse 37, Vienna, 1160, Austria. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, 3410 Worth Street, Dallas, TX, 75246, USA. · Rigshospitalet, DBCG Secretariat, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. · Mater Hospital, 25 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Centre GF Leclerc, 1 Rue du Professeur Marion, 21000, Dijon, France. · Northwestern University, 633 Clark Street, Chicago, IL, 60208, USA. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Ciudad Universitaria, s/n, 28040, Madrid, Spain. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada. · Arizona Oncology, US Oncology, 3700 W. State Route 89A, Sedona, AZ, 86336, USA. · GlaxoSmithKline, 1250 S Collegeville Road, Collegeville, PA, 19426, USA. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Pubmed 25888246
  • Vered Stearns, Kimmel Cancer Center, Johns Hopkins, Baltimore, MD · Judith-Anne W. Chapman, Aurélie Le Maitre, Jessica Kundapur, and Lois E. Shepherd, NCIC Clinical Trials Group, Queen's University, Kingston · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada · Cynthia X. Ma, Siteman Cancer Center, Washington University, St Louis, MO · Matthew J. Ellis, Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX · James N. Ingle, Mayo Clinic, Rochester, MN · G. Thomas Budd, Cleveland Clinic, Cleveland, OH · George W. Sledge, Stanford University, San Francisco, CA · Pedro E.R. Liedke and Paul E. Goss, Harvard University · Paul E. Goss, Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA · Manuela Rabaglio, Inselspital University Hospital and International Breast Cancer Study Group Coordinating Center, Berne, Switzerland · and Pedro E.R. Liedke, Hospital de Clínicas de Porto Alegre and Instituto do Cancer Mãe de Deus, Oncologia, Porto Alegre, Rio Grande do Sul, Brazil. · Pubmed 25512454
2014
  • Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Hospital Arnau de Vilanova de Valencia, Valencia, Spain. Electronic address: · Institut Regional du Cancer en Franche-Comté, Centre Hospitalier Universitaire de Besançon, Besançon, France. · Sandro Pitigliani Medical Oncology Department, Nuovo Ospedale di Prato, Istituto Toscano Tumori, Prato, Italy. · University Hospital 12 de Octubre, Madrid, Spain. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. · Institut Curie, Université Paris Descartes, Paris, France. · Royal Marsden Hospital and The Institute of Cancer Research, London, UK. · Department of Gynaecology, Martin-Luther-Universität Halle-Wittenberg, Halle an der Saale, Germany. · F Hoffmann-La Roche Ltd, Basel, Switzerland. · Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Scienco Klinico, Barcelona, Spain. · Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 25047747
  • Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital · Kathleen I. Pritchard, Sunnybrook Odette Cancer Center · Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto · Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa · Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center · Brian Findlay, Niagara Health System, Walker Family Cancer Center · Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario · Michael Vallis, Dalhousie University, Halifax, Nova Scotia · André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada · Jennifer A. Ligibel, Dana-Farber Cancer Institute · George L. Blackburn, Beth Israel Deaconess Medical Center · Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA · and Julie R. Gralow, University of Washington, Seattle, WA. · Pubmed 24934783
  • Department of Medicine, Division of Medical Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Electronic address: · York University, Department of Psychology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, Patient and Family Support, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. · Department of Surgery, Division of General Surgery, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. · Department of Medicine, Division of Medical Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. · Department of Research Design and Biostatistics, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. · Pubmed 24290865
2013
  • Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 24267730
  • Ian S. Dayes, Tim J. Whelan, Jim A. Julian, Sameer Parpia, and Mark N. Levine, McMaster University · Tim J. Whelan, Jim A. Julian, Sameer Parpia, Kathleen I. Pritchard, and Mark N. Levine, Ontario Clinical Oncology Group · Ian S. Dayes, Tim J. Whelan, and Mark N. Levine, Juravinski Cancer Centre · Donna Reise, Talspar Nursing Services · Jennifer Wiernikowski, Hamilton Health Sciences, Hamilton · Kathleen I. Pritchard and Lee Manchul, University of Toronto · Kathleen I. Pritchard, Odette Sunnybrook Cancer Centre · Lee Manchul, University Health Network, Toronto · David Paul D'Souza and Lyn Kligman, London Regional Cancer Program, London · David Paul D'Souza, University of Western Ontario, London, Ontario · Linda LeBlanc, Dr Leon Richard Oncology Centre, Moncton, New Brunswick · Margaret L. McNeely, University of Alberta · and Margaret L. McNeely, Cross Cancer Institute, Edmonton, Alberta, Canada. · Pubmed 24043733
  • Sunnybrook Research Institute, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 24190125
2012
  • Sunnybrook Odette Cancer Centre, The University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada. · Pubmed 22042366
2011
  • Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · Pubmed 21911723
2010
  • Sunnybrook Odette Cancer Centre and University of Toronto, 2075 Bayview Avenue, M4N 3M5, Toronto, ON, Canada. · Pubmed 20632084
  • Sunnybrook Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. · Pubmed 20177965
2009
  • Loyola University Stritch School of Medicine, Maywood, IL, USA. Electronic address: · Southwest Oncology Group Statistical Center, Seattle, WA, USA. · University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. · Ohio State University Health Center, Columbus, OH, USA. · Louisiana State University, Shreveport, LA, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Flower Memorial Hospital, Sylvania, OH, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Mayo Clinic, Rochester, MN, USA. · Toronto Sunnybrook Regional Cancer Centre, Toronto, ON, USA. · University of Michigan, Ann Arbor, MI, USA. · Loyola University Stritch School of Medicine, Maywood, IL, USA. · Johns Hopkins Medical Center, Baltimore, MD, USA. · University of California, San Francisco, San Francisco, CA, USA. · Vermont Cancer Center and University of Vermont, Burlington, VT, USA. · The Angeles Clinic and Research Institute, Santa Monica, CA, USA. · Baylor College of Medicine, Houston, TX, USA. · Pubmed 20004966
  • Sunnybrook Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5. · Pubmed 20030883
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2015
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Avenue, Toronto, ON, M5G 1X4, Canada. · Pubmed 25833209
  • From the Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON (T.J.W., M.N.L.), Tom Baker Cancer Centre, Calgary, AB (I.A.O., P.C.), BC Cancer Agency-Vancouver Island Centre, Victoria, BC (I.A.O.), Queen's University and NCIC Clinical Trials Group, Kingston, ON (W.R.P., Y.M., J.-A.W.C., B.E.C.), University of Toronto and Sunnybrook Odette Cancer Centre, Toronto (I.A., K.I.P.), Centre Universitaire de Sherbrooke at Fleurimont Hospital, Sherbrooke, QC (A.N.), Université de Montréal, Montreal (P.R.), Laval University and L'Hôtel-Dieu de Québec, Quebec, QC (A.F.), Princess Margaret Hospital, Toronto (L.M., D.R.M.), Cross Cancer Institute, Edmonton, AB (S.C.), Nova Scotia Cancer Centre, Halifax (M.C.N), Northeastern Ontario Regional Cancer Centre, Sudbury (J.B.), and BC Cancer Agency-Vancouver Centre, Vancouver, BC (K.G.) - all in Canada · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.H.C.) · Cancer Research UK-Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom (K.A.V.) · Ohio State University Wexner Medical Center, Columbus (J.R.W.) · and the University of Michigan Comprehensive Cancer Center, Ann Arbor (L.J.P.). · Pubmed 26200977
  • Toronto Health Economics and Technology Assessment Collaborative (THETA), University of Toronto, Suite 658, 144 College Street, Toronto, ON, M5S 3M2, Canada, · Pubmed 25962692
  • Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy. · Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy · Pubmed 25908555
  • Department of Medicine, University of Toronto, 27 King's College Cir, Toronto, ON, M5S 1A1, Canada. · Pubmed 25542270
2014
  • Imaging Research - Physical Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Imaging Research - Physical Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Department of Radiation Oncology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 24939867
  • Sunnybrook Research Institute and Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Department of Medical Biophysics and Medical Imaging, University of Toronto, Toronto, Ontario, Canada; Smarter Imaging Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 24536050
2011
  • Department of Medicine, Division of Clinical Epidemiology at the Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. · Pubmed 20976543
  • Ontario Institute for Cancer Research, Ontario, Canada. · Pubmed 22042959
2010
  • Division of Medical Oncology, Sunnybrook Odette Cancer Centre, The University of Toronto, Toronto, Ontario, Canada, M4N 3M5. · Pubmed 20421266
  • Sunnybrook Odette Cancer Centre, Ontario Clinical Oncology Group, University of Toronto, 2075 Bayview Ave, Toronto M4N3M5, Ontario, Canada. · Pubmed 20026801
  • Division of Medical Oncology, Sunnybrook Odette Cancer Centre, The University of Toronto, Toronto, Ontario M4N 3M5, Canada. · Pubmed 20421264
  • Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Canada. · Pubmed 20142325
  • Division of Medical Oncology, Sunnybrook Odette Cancer Centre, The University of Toronto, Toronto, Ontario, Canada. · Pubmed 20124175
Probable:    Miscellaneous institutions in Toronto      
2018
  • a Department of Medicine , Sunnybrook Odette Cancer Centre , Toronto , Canada. · b Department of Medical Oncology and Haematology , CancerCare Manitoba , Winnipeg , Canada. · Pubmed 29601247
2017
  • Carolyn Taylor, Frances K. Duane, David Dodwell, Richard Gray, Zhe Wang, Yaochen Wang, Richard Peto, and Paul McGale, University of Oxford, Oxford, United Kingdom · Candace Correa, Regional Cancer Center, Utica, NY · Marianne C. Aznar, Rigshospitalet, Copenhagen · Marianne Ewertz, Odense University Hospital, Odense, Denmark · Stewart J. Anderson, University of Pittsburgh, Pittsburgh, PA · Jonas Bergh, Karolinska Institutet and University Hospital, Stockholm, Sweden · Reshma Jagsi and Lori Pierce, University of Michigan, Ann Arbor MI · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto · Tim Whelan, Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada · and Sandra Swain, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC. · Pubmed 28319436
2016
  • INSERM and Paris South University UMR-S0776, Biological Rhythms and Cancers and APHP, Chronotherapy Unit, Department of Oncology, Paul Brousse Hospital, 12-14 Avenue Paul Vaillant Couturier, 94800, Villejuif, France. · Cancer Chronotherapy Unit, Warwick Medical School, Coventry, and Department of Oncology, Queen Elisabeth Hospital Brimingham, Brimingham, UK. · Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada. · Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA, 94305-5717, USA. · Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Department of Medicine, University of Ottawa, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada. · Department of Research Design and Biostatistics, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada. · Pubmed 26260726
2015
  • From the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · Sunnybrook Research Institute, Toronto (K.I.P.) and Juravinski Cancer Center, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), Duke University Medical Center, Durham (J.A.O.), Wake Forest University Health Service, Winston-Salem (L.I.W.), and Southeast Clinical Oncology Research Consortium, Goldsboro (J.N.A.) - all in North Carolina · Mayo Clinic, Jacksonville, FL (E.A.P.) · University of Maryland School of Medicine, Baltimore (J.A.O.), and National Institutes of Health, Bethesda (J.Z., T.L.) - both in Maryland · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.) - both in Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Baylor College of Medicine, Houston (M.J.E.), and University of Texas, San Antonio (P.R.) - both in Texas · Washington University, St. Louis (M.J.E.) · Allegheny General Hospital (S.P.) and University of Pittsburgh (A.M.B.) - both in Pittsburgh · the Department of Medical Oncology and Breast Center, Yonsei University College of Medicine, Seoul, South Korea (S.P.) · Emory University, Atlanta (W.C.W.) · Irish Clinical Oncology Research Group, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · University of Hawaii Cancer Center, Honolulu (J.L.B.) · and Stanford University, Stanford, CA (G.W.S.) · Pubmed 26412349
  • Transformative Pathology, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Informatics and Bio-Computing, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. · Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Leeds Institute of Cancer and Pathology and Cancer Research UK Centre, St James' University Hospital, Leeds, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of Toronto, Toronto, ON, Canada. · McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. · NCIC Clinical Trials Group (NCIC CTG] and Queen's University, Kingston, ON, Canada. · Pubmed 26372731
2014
  • Affiliations of authors: Transformative Pathology, Ontario Institute for Cancer Research, Toronto, ON, Canada (JMSB, MS) · Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, UK (JMSB) · Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (JMSB) · Institute of Health Policy Management and Evaluation, University of Edinburgh, Toronto, ON, Canada (KIP) · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada (KIP). · Pubmed 24402423
  • Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Columbia University Medical Center, New York, NY, USA. · University of Toronto, Toronto, ON, Canada. · Mayo Clinic, Rochester, MN, USA. · Johns Hopkins Oncology Centre, School of Medicine, Baltimore, MD, USA. · Allan Blair Cancer Centre, Regina, SK, Canada. · Carle CCOP, Urbana-Champaign, IL, USA. · University of North Carolina/Lineberger Comp Cancer Center, Chapel Hill, NC, USA. · University of Washington, Seattle, WA, USA. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Massachusetts General Hospital, Boston, MA, USA. · Pubmed 24636210
2012
2010
  • Sunnybrook Odette Cancer Centre, Toronto, Ontario M4N 3M5 Canada. · Pubmed 21172080
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2010
  • 5-105 610 University Avenue, Toronto, Ontario M5G 2M9, Canada. · Pubmed 20682606
Probable:    McMaster University   Contact    
2018
  • From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Chicago Stritch School of Medicine, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O.) - both in North Carolina · Mayo Clinic, Jacksonville, FL (M.P.G.) · National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L., J.A.) · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Washington University, St. Louis (M.J.E.) · National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and University of Pittsburgh (A.M.B.), Pittsburgh · Emory University, Atlanta (W.C.W.) · University of Texas, San Antonio (P.M.R.) · Cancer Trials Ireland, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · and University of Hawaii Cancer Center, Honolulu (J.L.B.). · Pubmed 29860917
2012
  • Ontario Clinical Oncology Group, McMaster University, Hamilton, Canada. · Pubmed 22393089
2016
  • From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston · the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.) · Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada · Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.) · University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.) · University of Washington School of Medicine, Seattle (J.G.) · Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.) · Colorado Cancer Research Program, Denver (K.S.) · Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.) · Memorial Sloan Kettering Cancer Center, New York (C.H.) · University of Arizona, Tucson (A.S.) · and Highlands Oncology Group, Fayetteville, AR (J.T.B.). · Pubmed 27264120
2015
  • From the Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON (T.J.W., M.N.L.), Tom Baker Cancer Centre, Calgary, AB (I.A.O., P.C.), BC Cancer Agency-Vancouver Island Centre, Victoria, BC (I.A.O.), Queen's University and NCIC Clinical Trials Group, Kingston, ON (W.R.P., Y.M., J.-A.W.C., B.E.C.), University of Toronto and Sunnybrook Odette Cancer Centre, Toronto (I.A., K.I.P.), Centre Universitaire de Sherbrooke at Fleurimont Hospital, Sherbrooke, QC (A.N.), Université de Montréal, Montreal (P.R.), Laval University and L'Hôtel-Dieu de Québec, Quebec, QC (A.F.), Princess Margaret Hospital, Toronto (L.M., D.R.M.), Cross Cancer Institute, Edmonton, AB (S.C.), Nova Scotia Cancer Centre, Halifax (M.C.N), Northeastern Ontario Regional Cancer Centre, Sudbury (J.B.), and BC Cancer Agency-Vancouver Centre, Vancouver, BC (K.G.) - all in Canada · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.H.C.) · Cancer Research UK-Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom (K.A.V.) · Ohio State University Wexner Medical Center, Columbus (J.R.W.) · and the University of Michigan Comprehensive Cancer Center, Ann Arbor (L.J.P.). · Pubmed 26200977
  • Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy. · Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy · Pubmed 25908555
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 110 total) written by Kathleen I. Pritchard about Breast Neoplasms:

  • An update on treatment for post-menopausal metastatic breast cancer in elderly patients. 2018
  • Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis. 2018
  • Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. 2018
  • Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27. 2017
  • Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32. 2017
  • Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial. 2017
  • 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. 2017
  • Extended adjuvant therapy: the role of subset analyses. 2017
  • A priori Prediction of Neoadjuvant Chemotherapy Response and Survival in Breast Cancer Patients using Quantitative Ultrasound. 2017
  • Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials. 2017
Show List of Full Article Records
Google Searches

Learn more about Kathleen I. Pritchard using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Toronto
Miscellaneous institutions in Toronto
McMaster University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Toronto
2018
  • Institute of Health Policy, Management and Evaluation, University of Toronto, Canada; Department of Oncology, Western University, London Regional Cancer Program, London, ON, Canada. Electronic address: · Institute of Health Policy, Management and Evaluation, University of Toronto, Canada; Department of Medical Oncology and Haematology, University of Manitoba and CancerCare Manitoba, MB, Canada. · Institute of Health Policy, Management and Evaluation, University of Toronto, Canada; Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, ON, Canada. · Department of Medicine, Sunnybrook Health Sciences Centre, ON, Canada. · Institute of Health Policy, Management and Evaluation, University of Toronto, Canada; Department of Pediatrics, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. · Pubmed 29331750
2017
  • Penn State Hershey Cancer Institute, Penn State Hershey Medical Center, Hershey, Pennsylvania. · Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. · Sunnybrook Odette Cancer Centre, Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada. · Oncology, Mayo Clinic, Rochester, Minnesota. · Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. · Stanford University Medical Center, Stanford, California. · International Breast Cancer Study Group Coordinating Center and Inselspital, Bern, Switzerland. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Lebanon VA Medical Center, Lebanon, Pennsylvania. · Pubmed 28464211
  • Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Children's Hospital of Eastern Ontario, Ottawa, ON, Canada. · University Health Network, University of Toronto, Toronto, ON, Canada. · Canadian Cancer Trials Group (CCTG), Cancer Research Institute, Queen's University, Kingston, ON, Canada. · British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada. · Dana-Farber Cancer Institute, Boston, MA, USA. · Columbia University Medical Center, New York, NY, USA. · National Surgical Adjuvant Breast and Bowel Project and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Mayo Clinic College of Medicine, Rochester, MN, USA. · Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, ON, Canada. · Juravinski Cancer Centre, Hamilton, ON, Canada. · Allan Blair Cancer Center, Regina, SK, Canada. · British Columbia Cancer Agency, Vancouver Island Center, University of British Columbia, Vancouver, BC, Canada. · Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Pubmed 28447237
  • Ian Smith and Mitch Dowsett, Royal Marsden Hospital · Institute of Cancer Research, London, United Kingdom · Denise Yardley and Howard Burris, Sarah Cannon Research Institute · Tennessee Oncology, Nashville, TN · Richard De Boer, Royal Melbourne and Western Hospitals, Melbourne, Australia · Dino Amadori, Istituto Scientifico Romagnolo per lo Studio e la Cura del Tumori Istituto di Ricovero eCura a Carattere Scientifico, Meldola · Lisa Comarella, CROS NT, Verona, Italy · Kristi McIntyre and Joyce O'Shaughnessy, Texas Oncology, US Oncology · Joyce O'Shaughnessy, Baylor University Medical Center · Baylor Charles A. Sammons Cancer Center · The US Oncology Network, Dallas, TX · Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark · Michael Gnant, Medical University of Vienna, Vienna, Austria · Walter Jonat, Universitätsklinikum Schleswig-Holstein, Kiel, Germany · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada · Lowell Hart, Florida Cancer Specialists, Fort Myers, FL · Susan Poggio and Barbara Wamil, Novartis Pharmaceuticals Corporation, East Hanover, NJ · and Herve Salomon, Novartis Pharma, Rueil-Malmaison, France. · Pubmed 28113032
  • From the Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford (H.P., R.G., J. Braybrooke, C.D., C.T., P.M., R.P.), and Royal Marsden Hospital and Institute of Cancer Research, London (M.D.) - both in the United Kingdom · Sunnybrook Health Sciences Centre and the University of Toronto, Toronto (K.I.P.) · Karolinska Institutet and Karolinska University Hospital, Stockholm (J. Bergh) · and the University of Michigan Comprehensive Cancer Center, Ann Arbor (D.F.H.). · Pubmed 29117498
  • Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 29031779
  • Physical Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Radiation Oncology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 28401902
  • Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada · British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Kaleidoscope Strategic, Inc., Toronto, Ontario, Canada. · Tom Baker Cancer Centre and University of Calgary, Alberta, Canada. · Deschênes-Fabia Center for Breast Disease, Quebec, Canada. · Division of Medical Oncology, Dalhousie University, and Atlantic Clinical Cancer Research Unit, Halifax, Nova Scotia, Canada. · Pubmed 27864574
2016
  • Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology, University of Western Ontario, London, Ontario, Canada. · Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 27776294
  • Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 27768924
  • Karolinska Institutet and University Hospital, Stockholm, Sweden · Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom. · Pubmed 26786914
  • a Department of Medicine , University of Toronto , Toronto , Canada. · Pubmed 27539883
  • Division of Geriatric Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. · AD Clinic, Centre for Brain Health, 2nd Floor 2215, Wesbrook Mall, Vancouver, V6T 1Z3, BC, Canada. · Department of Family & Community Medicine Faculty of Medicine, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Canada. · Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada. · Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Institute for Clinical Evaluative Sciences, Toronto, ON, Canada. · Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada. · Pubmed 27432418
  • Canadian Cancer Trials Group (Formerly, NCIC Clinical Trials Group), Queen's University, 10 Stuart St, Kingston, ON, Canada. · Massachusetts General Hospital, Harvard University, Boston, MA, USA. · bioTheranostics Inc, San Diego, CA, USA. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. · Canadian Cancer Trials Group (Formerly, NCIC Clinical Trials Group), Queen's University, 10 Stuart St, Kingston, ON, Canada. · McGill University, Montreal, QC, Canada. · Pubmed 27116182
  • Canadian Cancer Trials Group (formerly, NCIC Clinical Trials Group), Queen's University, Kingston, ON, Canada. · Canadian Cancer Trials Group (formerly, NCIC Clinical Trials Group), Queen's University, Kingston, ON, Canada. · Mayo Clinic, Rochester, MN, USA. · University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. · British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC, Canada. · Juravinski Cancer Centre at Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Pubmed 27006189
  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota. · Baylor Breast Center, Houston, Texas. · Massachusetts General Hospital Cancer Center, Harvard University, Boston, Massachusetts. · Canadian Cancer Trials Group, Kingston, Ontario, Canada. · RIKEN Center for Integrative Medical Science, Yokohama, Japan. · University of Tokyo, Tokyo, Japan. · Johns Hopkins School of Medicine, Baltimore, Maryland. · Sunnybrook Odette Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Pubmed 27758888
  • Physical Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. · Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Radiation Oncology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 27105515
  • Center for Oncology and Hematology, Wilhelminen Hospital, Vienna, Austria. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Royal Marsden Hospital, London, UK. Electronic address: · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. Electronic address: · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. Electronic address: · Mater Hospital, North Sydney, NSW, Australia. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Centre GF Leclerc, Dijon, France. Electronic address: · Northwestern University, Chicago, IL, USA. Electronic address: · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: · Arizona Oncology, US Oncology, Sedona, AZ, USA. Electronic address: · GlaxoSmithKline, Collegeville, PA, USA. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Pubmed 26829011
  • Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · bioTheranostics, Inc., San Diego, CA, USA. · bioTheranostics, Inc., San Diego, CA, USA. · Trovagene Inc., San Diego, CA, USA. · Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada. · Pubmed 26728744
  • Mark N. Levine, Jim A. Julian, and Louise Bordeleau, McMaster University, Hamilton · Mark N. Levine and Louise Bordeleau, Hamilton Health Sciences Juravinski Cancer Centre, Hamilton · Mark N. Levine and Jim A. Julian, Ontario Clinical Oncology Group and Escarpment Cancer Research Institute, Hamilton · Philippe L. Bedard, Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, University of Toronto, Toronto · Phillipe L. Bedard, Princess Margaret Hospital, Toronto · Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, Odette Sunnybrook Regional Cancer Centre · Toronto · and Brian Higgins, Peel Regional Cancer Centre, Mississauga, Ontario, Canada. · Pubmed 26598746
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX · David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ · Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels · Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium · Hope S. Rugo, University of California, San Francisco · Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA · Howard A. Burris III, Sarah Cannon Research Institute, Nashville, TN · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada · Mario Campone, Centre de Recherche en Cancerologie, Nantes-Saint-Herblain · Thomas Bachelot, Centre Léon Bérard, Lyon, France · Shinzaburo Noguchi, Osaka University Medical School · Norikazu Masuda, Osaka National Hospital, Osaka, Japan · Alejandra T. Perez, Memorial Cancer Institute, Hollywood, FL · Mikhail Shtivelband, Ironwood Cancer & Research Centers, Chandler, AZ · Shaker Dakhil, Cancer Center of Kansas, Wichita, KS · Douglas M. Robinson, Wei He, Abhishek Garg, E. Robert McDonald III, Hans Bitter, and Alan Huang, Novartis Institutes for BioMedical Research, Cambridge, MA · and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 26503204
2015
  • Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver · Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia · Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec · Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston · Susan Dent, Ottawa Health Research Institute, Ottawa · Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto · Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario · Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada · Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia · Bella Kaufman, Sheba Medical Centre, Tel Hashomer · Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel · Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg · Sergei Tjulandin, Russian Cancer Research Center, Moscow · Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia · Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy · Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain · Lee S. Schwartzberg, West Clinic, Memphis, TN · Arnd Nusch, Praxis, Velbert, Germany · Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom · Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan · Anne P. Connor, GlaxoSmithKline, Collegeville, PA · and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil. · Pubmed 25779558
  • Mater Hospital, Sydney, Australia. Electronic address: · Royal Marsden Hospital, London, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, United States. · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. · UT MD Anderson Cancer Center, Houston, TX, United States. · Centre GF Leclerc, Dijon, France. · Northwestern University, Chicago, IL, United States. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Massachusetts General Hospital, Boston, MA, United States. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. · Arizona Oncology, US Oncology, Sedona, AZ, United States. · GlaxoSmithKline, Collegeville, PA, United States; GlaxoSmithKline, Uxbridge, UK. · Pubmed 25752740
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (PJG) · NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (WRP, LES, BEC) · NCIC Clinical Trials Group, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada (KAG) · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (JAL) · Columbia University Medical Center, New York, NY (DLH) · National Surgical Adjuvant Breast and Bowel Project, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA (PR) · Vanderbilt-Ingram Medical Center, Vanderbilt University Medical Center, Nashville, TN (IAM) · Mayo Clinic College of Medicine, Rochester, MN (TJH) · Centre de recherche du CHU de Québec, Unité de recherche en santé des populations Hôpital du Saint-Sacrement, Quebec, Quebec, Canada (JL) · National Cancer Research Institute Breast Clinical Studies Group, London, UK (AMT) · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada (KIP) · Juravinski Cancer Center at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (TJW, SDM) · Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (HIC) · British Columbia Cancer Agency, Fraser Valley Center, Surrey, British Columbia, Canada (CDO) · University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada (KST) · British Columbia Cancer Agency - Vancouver Island Center, University of British Columbia, British Columbia, Canada (VB) · Ontario Cancer Institute, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada (VS). · Pubmed 25740979
  • Transformative Pathology, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Informatics and Bio-Computing, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. · Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Leeds Institute of Cancer and Pathology and Cancer Research UK Centre, St James' University Hospital, Leeds, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of Toronto, Toronto, ON, Canada. · McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. · NCIC Clinical Trials Group (NCIC CTG] and Queen's University, Kingston, ON, Canada. · Pubmed 26372731
  • Center for Oncology and Hematology, Wilhelminen Hospital, Montleartstrasse 37, Vienna, 1160, Austria. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, 3410 Worth Street, Dallas, TX, 75246, USA. · Rigshospitalet, DBCG Secretariat, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. · Mater Hospital, 25 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Centre GF Leclerc, 1 Rue du Professeur Marion, 21000, Dijon, France. · Northwestern University, 633 Clark Street, Chicago, IL, 60208, USA. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Ciudad Universitaria, s/n, 28040, Madrid, Spain. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada. · Arizona Oncology, US Oncology, 3700 W. State Route 89A, Sedona, AZ, 86336, USA. · GlaxoSmithKline, 1250 S Collegeville Road, Collegeville, PA, 19426, USA. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Pubmed 25888246
  • Vered Stearns, Kimmel Cancer Center, Johns Hopkins, Baltimore, MD · Judith-Anne W. Chapman, Aurélie Le Maitre, Jessica Kundapur, and Lois E. Shepherd, NCIC Clinical Trials Group, Queen's University, Kingston · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada · Cynthia X. Ma, Siteman Cancer Center, Washington University, St Louis, MO · Matthew J. Ellis, Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX · James N. Ingle, Mayo Clinic, Rochester, MN · G. Thomas Budd, Cleveland Clinic, Cleveland, OH · George W. Sledge, Stanford University, San Francisco, CA · Pedro E.R. Liedke and Paul E. Goss, Harvard University · Paul E. Goss, Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA · Manuela Rabaglio, Inselspital University Hospital and International Breast Cancer Study Group Coordinating Center, Berne, Switzerland · and Pedro E.R. Liedke, Hospital de Clínicas de Porto Alegre and Instituto do Cancer Mãe de Deus, Oncologia, Porto Alegre, Rio Grande do Sul, Brazil. · Pubmed 25512454
2014
  • Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Hospital Arnau de Vilanova de Valencia, Valencia, Spain. Electronic address: · Institut Regional du Cancer en Franche-Comté, Centre Hospitalier Universitaire de Besançon, Besançon, France. · Sandro Pitigliani Medical Oncology Department, Nuovo Ospedale di Prato, Istituto Toscano Tumori, Prato, Italy. · University Hospital 12 de Octubre, Madrid, Spain. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. · Institut Curie, Université Paris Descartes, Paris, France. · Royal Marsden Hospital and The Institute of Cancer Research, London, UK. · Department of Gynaecology, Martin-Luther-Universität Halle-Wittenberg, Halle an der Saale, Germany. · F Hoffmann-La Roche Ltd, Basel, Switzerland. · Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Scienco Klinico, Barcelona, Spain. · Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 25047747
  • Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital · Kathleen I. Pritchard, Sunnybrook Odette Cancer Center · Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto · Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa · Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center · Brian Findlay, Niagara Health System, Walker Family Cancer Center · Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario · Michael Vallis, Dalhousie University, Halifax, Nova Scotia · André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada · Jennifer A. Ligibel, Dana-Farber Cancer Institute · George L. Blackburn, Beth Israel Deaconess Medical Center · Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA · and Julie R. Gralow, University of Washington, Seattle, WA. · Pubmed 24934783
  • Department of Medicine, Division of Medical Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Electronic address: · York University, Department of Psychology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, Patient and Family Support, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. · Department of Surgery, Division of General Surgery, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. · Department of Medicine, Division of Medical Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. · Department of Research Design and Biostatistics, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. · Pubmed 24290865
2013
  • Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 24267730
  • Ian S. Dayes, Tim J. Whelan, Jim A. Julian, Sameer Parpia, and Mark N. Levine, McMaster University · Tim J. Whelan, Jim A. Julian, Sameer Parpia, Kathleen I. Pritchard, and Mark N. Levine, Ontario Clinical Oncology Group · Ian S. Dayes, Tim J. Whelan, and Mark N. Levine, Juravinski Cancer Centre · Donna Reise, Talspar Nursing Services · Jennifer Wiernikowski, Hamilton Health Sciences, Hamilton · Kathleen I. Pritchard and Lee Manchul, University of Toronto · Kathleen I. Pritchard, Odette Sunnybrook Cancer Centre · Lee Manchul, University Health Network, Toronto · David Paul D'Souza and Lyn Kligman, London Regional Cancer Program, London · David Paul D'Souza, University of Western Ontario, London, Ontario · Linda LeBlanc, Dr Leon Richard Oncology Centre, Moncton, New Brunswick · Margaret L. McNeely, University of Alberta · and Margaret L. McNeely, Cross Cancer Institute, Edmonton, Alberta, Canada. · Pubmed 24043733
  • Sunnybrook Research Institute, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 24190125
2012
  • Sunnybrook Odette Cancer Centre, The University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada. · Pubmed 22042366
2011
  • Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · Pubmed 21911723
2010
  • Sunnybrook Odette Cancer Centre and University of Toronto, 2075 Bayview Avenue, M4N 3M5, Toronto, ON, Canada. · Pubmed 20632084
  • Sunnybrook Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. · Pubmed 20177965
2009
  • Loyola University Stritch School of Medicine, Maywood, IL, USA. Electronic address: · Southwest Oncology Group Statistical Center, Seattle, WA, USA. · University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. · Ohio State University Health Center, Columbus, OH, USA. · Louisiana State University, Shreveport, LA, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Flower Memorial Hospital, Sylvania, OH, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Mayo Clinic, Rochester, MN, USA. · Toronto Sunnybrook Regional Cancer Centre, Toronto, ON, USA. · University of Michigan, Ann Arbor, MI, USA. · Loyola University Stritch School of Medicine, Maywood, IL, USA. · Johns Hopkins Medical Center, Baltimore, MD, USA. · University of California, San Francisco, San Francisco, CA, USA. · Vermont Cancer Center and University of Vermont, Burlington, VT, USA. · The Angeles Clinic and Research Institute, Santa Monica, CA, USA. · Baylor College of Medicine, Houston, TX, USA. · Pubmed 20004966
  • Sunnybrook Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5. · Pubmed 20030883
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2015
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Avenue, Toronto, ON, M5G 1X4, Canada. · Pubmed 25833209
  • From the Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON (T.J.W., M.N.L.), Tom Baker Cancer Centre, Calgary, AB (I.A.O., P.C.), BC Cancer Agency-Vancouver Island Centre, Victoria, BC (I.A.O.), Queen's University and NCIC Clinical Trials Group, Kingston, ON (W.R.P., Y.M., J.-A.W.C., B.E.C.), University of Toronto and Sunnybrook Odette Cancer Centre, Toronto (I.A., K.I.P.), Centre Universitaire de Sherbrooke at Fleurimont Hospital, Sherbrooke, QC (A.N.), Université de Montréal, Montreal (P.R.), Laval University and L'Hôtel-Dieu de Québec, Quebec, QC (A.F.), Princess Margaret Hospital, Toronto (L.M., D.R.M.), Cross Cancer Institute, Edmonton, AB (S.C.), Nova Scotia Cancer Centre, Halifax (M.C.N), Northeastern Ontario Regional Cancer Centre, Sudbury (J.B.), and BC Cancer Agency-Vancouver Centre, Vancouver, BC (K.G.) - all in Canada · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.H.C.) · Cancer Research UK-Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom (K.A.V.) · Ohio State University Wexner Medical Center, Columbus (J.R.W.) · and the University of Michigan Comprehensive Cancer Center, Ann Arbor (L.J.P.). · Pubmed 26200977
  • Toronto Health Economics and Technology Assessment Collaborative (THETA), University of Toronto, Suite 658, 144 College Street, Toronto, ON, M5S 3M2, Canada, · Pubmed 25962692
  • Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy. · Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy · Pubmed 25908555
  • Department of Medicine, University of Toronto, 27 King's College Cir, Toronto, ON, M5S 1A1, Canada. · Pubmed 25542270
2014
  • Imaging Research - Physical Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Imaging Research - Physical Sciences, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Department of Radiation Oncology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 24939867
  • Sunnybrook Research Institute and Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Department of Medical Biophysics and Medical Imaging, University of Toronto, Toronto, Ontario, Canada; Smarter Imaging Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 24536050
2011
  • Department of Medicine, Division of Clinical Epidemiology at the Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. · Pubmed 20976543
  • Ontario Institute for Cancer Research, Ontario, Canada. · Pubmed 22042959
2010
  • Division of Medical Oncology, Sunnybrook Odette Cancer Centre, The University of Toronto, Toronto, Ontario, Canada, M4N 3M5. · Pubmed 20421266
  • Sunnybrook Odette Cancer Centre, Ontario Clinical Oncology Group, University of Toronto, 2075 Bayview Ave, Toronto M4N3M5, Ontario, Canada. · Pubmed 20026801
  • Division of Medical Oncology, Sunnybrook Odette Cancer Centre, The University of Toronto, Toronto, Ontario M4N 3M5, Canada. · Pubmed 20421264
  • Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Canada. · Pubmed 20142325
  • Division of Medical Oncology, Sunnybrook Odette Cancer Centre, The University of Toronto, Toronto, Ontario, Canada. · Pubmed 20124175
Miscellaneous institutions in Toronto
2018
  • a Department of Medicine , Sunnybrook Odette Cancer Centre , Toronto , Canada. · b Department of Medical Oncology and Haematology , CancerCare Manitoba , Winnipeg , Canada. · Pubmed 29601247
2017
  • Carolyn Taylor, Frances K. Duane, David Dodwell, Richard Gray, Zhe Wang, Yaochen Wang, Richard Peto, and Paul McGale, University of Oxford, Oxford, United Kingdom · Candace Correa, Regional Cancer Center, Utica, NY · Marianne C. Aznar, Rigshospitalet, Copenhagen · Marianne Ewertz, Odense University Hospital, Odense, Denmark · Stewart J. Anderson, University of Pittsburgh, Pittsburgh, PA · Jonas Bergh, Karolinska Institutet and University Hospital, Stockholm, Sweden · Reshma Jagsi and Lori Pierce, University of Michigan, Ann Arbor MI · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto · Tim Whelan, Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada · and Sandra Swain, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC. · Pubmed 28319436
2016
  • INSERM and Paris South University UMR-S0776, Biological Rhythms and Cancers and APHP, Chronotherapy Unit, Department of Oncology, Paul Brousse Hospital, 12-14 Avenue Paul Vaillant Couturier, 94800, Villejuif, France. · Cancer Chronotherapy Unit, Warwick Medical School, Coventry, and Department of Oncology, Queen Elisabeth Hospital Brimingham, Brimingham, UK. · Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada. · Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA, 94305-5717, USA. · Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Department of Medicine, University of Ottawa, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada. · Department of Research Design and Biostatistics, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada. · Pubmed 26260726
2015
  • From the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · Sunnybrook Research Institute, Toronto (K.I.P.) and Juravinski Cancer Center, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), Duke University Medical Center, Durham (J.A.O.), Wake Forest University Health Service, Winston-Salem (L.I.W.), and Southeast Clinical Oncology Research Consortium, Goldsboro (J.N.A.) - all in North Carolina · Mayo Clinic, Jacksonville, FL (E.A.P.) · University of Maryland School of Medicine, Baltimore (J.A.O.), and National Institutes of Health, Bethesda (J.Z., T.L.) - both in Maryland · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.) - both in Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Baylor College of Medicine, Houston (M.J.E.), and University of Texas, San Antonio (P.R.) - both in Texas · Washington University, St. Louis (M.J.E.) · Allegheny General Hospital (S.P.) and University of Pittsburgh (A.M.B.) - both in Pittsburgh · the Department of Medical Oncology and Breast Center, Yonsei University College of Medicine, Seoul, South Korea (S.P.) · Emory University, Atlanta (W.C.W.) · Irish Clinical Oncology Research Group, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · University of Hawaii Cancer Center, Honolulu (J.L.B.) · and Stanford University, Stanford, CA (G.W.S.) · Pubmed 26412349
  • Transformative Pathology, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Informatics and Bio-Computing, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. · Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Leeds Institute of Cancer and Pathology and Cancer Research UK Centre, St James' University Hospital, Leeds, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of Toronto, Toronto, ON, Canada. · McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. · NCIC Clinical Trials Group (NCIC CTG] and Queen's University, Kingston, ON, Canada. · Pubmed 26372731
2014
  • Affiliations of authors: Transformative Pathology, Ontario Institute for Cancer Research, Toronto, ON, Canada (JMSB, MS) · Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, UK (JMSB) · Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (JMSB) · Institute of Health Policy Management and Evaluation, University of Edinburgh, Toronto, ON, Canada (KIP) · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada (KIP). · Pubmed 24402423
  • Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Columbia University Medical Center, New York, NY, USA. · University of Toronto, Toronto, ON, Canada. · Mayo Clinic, Rochester, MN, USA. · Johns Hopkins Oncology Centre, School of Medicine, Baltimore, MD, USA. · Allan Blair Cancer Centre, Regina, SK, Canada. · Carle CCOP, Urbana-Champaign, IL, USA. · University of North Carolina/Lineberger Comp Cancer Center, Chapel Hill, NC, USA. · University of Washington, Seattle, WA, USA. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Massachusetts General Hospital, Boston, MA, USA. · Pubmed 24636210
2012
2010
  • Sunnybrook Odette Cancer Centre, Toronto, Ontario M4N 3M5 Canada. · Pubmed 21172080
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2010
  • 5-105 610 University Avenue, Toronto, Ontario M5G 2M9, Canada. · Pubmed 20682606
McMaster University
2018
  • From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Chicago Stritch School of Medicine, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O.) - both in North Carolina · Mayo Clinic, Jacksonville, FL (M.P.G.) · National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L., J.A.) · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Washington University, St. Louis (M.J.E.) · National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and University of Pittsburgh (A.M.B.), Pittsburgh · Emory University, Atlanta (W.C.W.) · University of Texas, San Antonio (P.M.R.) · Cancer Trials Ireland, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · and University of Hawaii Cancer Center, Honolulu (J.L.B.). · Pubmed 29860917
2012
  • Ontario Clinical Oncology Group, McMaster University, Hamilton, Canada. · Pubmed 22393089
2016
  • From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston · the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.) · Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada · Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.) · University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.) · University of Washington School of Medicine, Seattle (J.G.) · Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.) · Colorado Cancer Research Program, Denver (K.S.) · Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.) · Memorial Sloan Kettering Cancer Center, New York (C.H.) · University of Arizona, Tucson (A.S.) · and Highlands Oncology Group, Fayetteville, AR (J.T.B.). · Pubmed 27264120
2015
  • From the Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON (T.J.W., M.N.L.), Tom Baker Cancer Centre, Calgary, AB (I.A.O., P.C.), BC Cancer Agency-Vancouver Island Centre, Victoria, BC (I.A.O.), Queen's University and NCIC Clinical Trials Group, Kingston, ON (W.R.P., Y.M., J.-A.W.C., B.E.C.), University of Toronto and Sunnybrook Odette Cancer Centre, Toronto (I.A., K.I.P.), Centre Universitaire de Sherbrooke at Fleurimont Hospital, Sherbrooke, QC (A.N.), Université de Montréal, Montreal (P.R.), Laval University and L'Hôtel-Dieu de Québec, Quebec, QC (A.F.), Princess Margaret Hospital, Toronto (L.M., D.R.M.), Cross Cancer Institute, Edmonton, AB (S.C.), Nova Scotia Cancer Centre, Halifax (M.C.N), Northeastern Ontario Regional Cancer Centre, Sudbury (J.B.), and BC Cancer Agency-Vancouver Centre, Vancouver, BC (K.G.) - all in Canada · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.H.C.) · Cancer Research UK-Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom (K.A.V.) · Ohio State University Wexner Medical Center, Columbus (J.R.W.) · and the University of Michigan Comprehensive Cancer Center, Ann Arbor (L.J.P.). · Pubmed 26200977
  • Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy. · Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy · Pubmed 25908555
Unspecified
2016
  • Mark N. Levine, Jim A. Julian, and Louise Bordeleau, McMaster University, Hamilton · Mark N. Levine and Louise Bordeleau, Hamilton Health Sciences Juravinski Cancer Centre, Hamilton · Mark N. Levine and Jim A. Julian, Ontario Clinical Oncology Group and Escarpment Cancer Research Institute, Hamilton · Philippe L. Bedard, Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, University of Toronto, Toronto · Phillipe L. Bedard, Princess Margaret Hospital, Toronto · Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, Odette Sunnybrook Regional Cancer Centre · Toronto · and Brian Higgins, Peel Regional Cancer Centre, Mississauga, Ontario, Canada. · Pubmed 26598746
2014
  • Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital · Kathleen I. Pritchard, Sunnybrook Odette Cancer Center · Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto · Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa · Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center · Brian Findlay, Niagara Health System, Walker Family Cancer Center · Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario · Michael Vallis, Dalhousie University, Halifax, Nova Scotia · André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada · Jennifer A. Ligibel, Dana-Farber Cancer Institute · George L. Blackburn, Beth Israel Deaconess Medical Center · Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA · and Julie R. Gralow, University of Washington, Seattle, WA. · Pubmed 24934783
2013
  • Ian S. Dayes, Tim J. Whelan, Jim A. Julian, Sameer Parpia, and Mark N. Levine, McMaster University · Tim J. Whelan, Jim A. Julian, Sameer Parpia, Kathleen I. Pritchard, and Mark N. Levine, Ontario Clinical Oncology Group · Ian S. Dayes, Tim J. Whelan, and Mark N. Levine, Juravinski Cancer Centre · Donna Reise, Talspar Nursing Services · Jennifer Wiernikowski, Hamilton Health Sciences, Hamilton · Kathleen I. Pritchard and Lee Manchul, University of Toronto · Kathleen I. Pritchard, Odette Sunnybrook Cancer Centre · Lee Manchul, University Health Network, Toronto · David Paul D'Souza and Lyn Kligman, London Regional Cancer Program, London · David Paul D'Souza, University of Western Ontario, London, Ontario · Linda LeBlanc, Dr Leon Richard Oncology Centre, Moncton, New Brunswick · Margaret L. McNeely, University of Alberta · and Margaret L. McNeely, Cross Cancer Institute, Edmonton, Alberta, Canada. · Pubmed 24043733
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
Miscellaneous institutions in Hamilton
2015
  • From the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · Sunnybrook Research Institute, Toronto (K.I.P.) and Juravinski Cancer Center, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), Duke University Medical Center, Durham (J.A.O.), Wake Forest University Health Service, Winston-Salem (L.I.W.), and Southeast Clinical Oncology Research Consortium, Goldsboro (J.N.A.) - all in North Carolina · Mayo Clinic, Jacksonville, FL (E.A.P.) · University of Maryland School of Medicine, Baltimore (J.A.O.), and National Institutes of Health, Bethesda (J.Z., T.L.) - both in Maryland · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.) - both in Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Baylor College of Medicine, Houston (M.J.E.), and University of Texas, San Antonio (P.R.) - both in Texas · Washington University, St. Louis (M.J.E.) · Allegheny General Hospital (S.P.) and University of Pittsburgh (A.M.B.) - both in Pittsburgh · the Department of Medical Oncology and Breast Center, Yonsei University College of Medicine, Seoul, South Korea (S.P.) · Emory University, Atlanta (W.C.W.) · Irish Clinical Oncology Research Group, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · University of Hawaii Cancer Center, Honolulu (J.L.B.) · and Stanford University, Stanford, CA (G.W.S.) · Pubmed 26412349
2010
  • Department of Oncology, Juravinski Cancer Centre, 699 Concession St, Hamilton, Ontario, Canada L8V 5C2. · Pubmed 21060031
University of Edinburgh
2014
  • Affiliations of authors: Transformative Pathology, Ontario Institute for Cancer Research, Toronto, ON, Canada (JMSB, MS) · Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, UK (JMSB) · Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (JMSB) · Institute of Health Policy Management and Evaluation, University of Edinburgh, Toronto, ON, Canada (KIP) · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada (KIP). · Pubmed 24402423
Miscellaneous cities in Ontario
2013
  • Ian S. Dayes, Tim J. Whelan, Jim A. Julian, Sameer Parpia, and Mark N. Levine, McMaster University · Tim J. Whelan, Jim A. Julian, Sameer Parpia, Kathleen I. Pritchard, and Mark N. Levine, Ontario Clinical Oncology Group · Ian S. Dayes, Tim J. Whelan, and Mark N. Levine, Juravinski Cancer Centre · Donna Reise, Talspar Nursing Services · Jennifer Wiernikowski, Hamilton Health Sciences, Hamilton · Kathleen I. Pritchard and Lee Manchul, University of Toronto · Kathleen I. Pritchard, Odette Sunnybrook Cancer Centre · Lee Manchul, University Health Network, Toronto · David Paul D'Souza and Lyn Kligman, London Regional Cancer Program, London · David Paul D'Souza, University of Western Ontario, London, Ontario · Linda LeBlanc, Dr Leon Richard Oncology Centre, Moncton, New Brunswick · Margaret L. McNeely, University of Alberta · and Margaret L. McNeely, Cross Cancer Institute, Edmonton, Alberta, Canada. · Pubmed 24043733
2009
  • Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Toronto, Ontario M4N 3M5, Canada. · Pubmed 19819915
67 Other Locations Show
Yearly article counts 38171510131491650
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.